P.2.032 ZL006 has antidepressant effects and attenuates changes in dendritic spines associated with astrocytic impairment in mice
Sign Up to like & getrecommendations! Published in 2018 at "European Neuropsychopharmacology"
DOI: 10.1016/j.euroneuro.2017.12.071
Abstract: The NMDA receptor (NMDA-R) remains a promising target for treating CNS disorders including depression. Directly targeting NMDA-R is however liable to produce unwanted adverse effects. Previous studies demonstrate that nitric oxide (NO) synthase inhibitors are… read more here.
Keywords: depression; mice; changes dendritic; zl006 ... See more keywords